orchestrabiomed.com - OBIO Profit before deduction of interest, taxes, depreciation and amortization
Orchestra BioMed (OBIO) leverages global bioelectronics partnerships to diversify its client base. EBITDA dynamics demonstrate current resilience, with the metric recorded at 0.00. Business stability is supported by the integration of pharmaceuticals and devices in the US. Growth is driven by the implementation of the BackBeat system, which offers an alternative to traditional hypertension control medications.
Summary analytical data breakdowns for Orchestra BioMed (OBIO)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Orchestra BioMed|OBIO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio orchestrabiomed.com|OBIO - Company Aggregate Debts|Debts to Book Value Orchestra BioMed|OBIO - Company Long-Term Debts|Company Short-Term Indebtedness Orchestra BioMed|Interim Coverage Ratio orchestrabiomed.com
- earnings and market multiples details:
OBIO - Net Profit|Future Profit Orchestra BioMed|OBIO - P/E Multiple|Forward P/E Multiple Orchestra BioMed Inc.|OBIO - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orchestra BioMed|OBIO - Operating profit before deduction of amortization|Earnings per share for the trailing year Orchestra BioMed|OBIO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months orchestrabiomed.com|OBIO - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Orchestra BioMed
Summary company analytics:Orchestra BioMed
Defensive assets are selected based on their ability to generate stable cash flow, which for Orchestra BioMed (OBIO) is ensured by the commercialization of the BackStop platform and the growth of licensing payments. By analyzing monthly EBITDA dynamics, an investor assesses the net operating efficiency of the business excluding depreciation and taxes, determining the extent to which the scaling rates of ischemic heart disease therapy outpace the cost of capital.
Who Orchestra BioMed competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Anika - Operating profit EBITDA|Operating income before deduction of amortization inspiremd.com NSPR|zhjmedical.com (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani Medical)|Profit before payment of interest, taxes and amortization Xtant Medical Holdings, Inc.|Operating profit before deduction of amortization NeuroOne Medical Technologies Corp. (NMTC)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|Tenon Medical, Inc. (TNON) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization rewalk.com (LFWD)|Profit before payment of interest, taxes and amortization Autonomix Medical Inc.|IVF: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BBLG|Operating profit before deduction of amortization Axonics, Inc AXNX|Operating profit EBITDA BIOL (BIOLASE, Inc.)|Income before deduction of interest, taxes and amortization DYNT|Paragon 28 Corp - Operating profit EBITDA|Profit before interest, taxes and amortization INVO Bioscience, Inc.
